Skip to content

Sunquest Mitogen Genetics 6.3

by CliniSys, Inc

Sunquest Mitogen Genetics 6.3, a human genomic analysis interpretive software (FDA Class I; FDA product code OUG, Medical Device Data System) made by CliniSys, Inc, was listed in FDA GUDID on 12 Nov 2020 (UDI-DI B236SMG6300); the registry lists it as not in commercial distribution (GUDID) as of 23 Oct 2026.

Listed FDA GUDID listing, not in commercial distribution

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB236SMG6300 UDI-DI Date12 Nov 2020ListedStatusListed GUDID: not in commercial distribution

From the FDA record

Device description
Sunquest Mitogen™ Genetics supports laboratories in the management of patient genetic testing data, support reporting that includes variant information, and to transfer, store, and display test results and information.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Sunquest Mitogen Genetics
Generic name
Human genomic analysis interpretive software
Model / reference
6.3
Primary DI / UDI-DI
B236SMG6300
FDA product code
OUG
GMDN term
Human genomic analysis interpretive software
Device class
Class I
Regulation number
880.6310
GUDID distribution status
Not in Commercial Distribution

Similar devices

Other devices filed under FDA product code OUG (Medical Device Data System).

Other devices from CliniSys, Inc

See all devices from CliniSys, Inc →

Properties

  • Premarket exempt
  • Lot / batch number
Other properties (13, all answered No)